English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1945]
News [3588]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
A 'switch' that turns autoimmunity drugs into powerful anti-cancer treatments
A 'switch' that turns autoimmunity drugs into powerful anti-cancer treatments
ASCO 2020: Pembrolizumab plus chemotherapy demonstrated improvement in PFS for patients with metastatic triple-negative breast cancer
ASCO 2020: Pembrolizumab plus chemotherapy demonstrated improvement in PFS for patients with metastatic triple...
Clinical trial announced to study impact of severe COVID-19 infection on patients who receive stem cell transplants for blood cancers and disorders
Clinical trial announced to study impact of severe COVID-19 infection on patients who receive stem cell...
ASCO 2020: Durvalumab added to standard chemotherapy improved overall survival in mesothelioma
ASCO 2020: Durvalumab added to standard chemotherapy improved overall survival in mesothelioma
Potentially treatable genetic mutations revealed in subset of prostate cancer patients
Potentially treatable genetic mutations revealed in subset of prostate cancer patients
FDA approves atezolizumab for first-line treatment of metastatic NSCLC with high PD-L1 expression
FDA approves atezolizumab for first-line treatment of metastatic NSCLC with high PD-L1 expression
FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumour expression ≥1%)
FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumour expression ≥1%)
Scientists identify promising immunotherapy combination for paediatric brain cancer
Scientists identify promising immunotherapy combination for paediatric brain cancer
Treatment guidance for lung cancer patients during the COVID-19 pandemic
Treatment guidance for lung cancer patients during the COVID-19 pandemic
Combination of chemo and immunotherapy is shown to work against metastatic bladder cancer
Combination of chemo and immunotherapy is shown to work against metastatic bladder cancer
<1...148149150151152...359>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top